Pfizer moves forward with once-daily version of weight loss pill after setbacks

The company plans to conduct studies in the second half of the year evaluating multiple doses of the drug.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.